pharma news

News

UK's Claret Capital raises €575m for European biotechs

London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."

News

Novo Nordisk's IL-6 drug flunks two more heart trials

Novo Nordisk has opted to discontinue two late-stage trials of IL-6 inhibitor ziltivekimab in heart failure, after taking an interim look at the data.

News

Novartis hit as Lp(a) drug fails cardio outcomes trial

Novartis shares have slipped after it revealed its Lp(a)-targeted drug, pelacarsen, failed to reduce cardiovascular risks in a major phase 3 trial.

News

FDA overrides adcomm and approves AZ's oral SERD

The FDA has gone against the advice of its own expert advisors and approved AstraZeneca's Etcamah as a frontline treatment for breast cancer.

News

Person holds hand of elderly lady; grey colour scheme

Major trial of Roche Alzheimer's drug kicks off in Europe

The PrevenTRON trial of Roche's Brainshuttle drug trontinemab in preclinical Alzheimer's disease has gotten underway in the UK.

News

Merck rare tumour drug Ezmekly backed for NHS use

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

UK's Claret Capital raises €575m for European biotechs

Novo Nordisk's IL-6 drug flunks two more heart trials

Novartis hit as Lp(a) drug fails cardio outcomes trial

FDA overrides adcomm and approves AZ's oral SERD

Major trial of Roche Alzheimer's drug kicks off in Europe

Merck rare tumour drug Ezmekly backed for NHS use

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks